Robert J. Young - Concepedia

Author

Robert J. Young

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Joanna Turner, Morris Dembo, R J Young, R Young, R. J. Young, R. Young, R.J Young, R.J. Young, Robert J Young, Robert J. Young

440

Publications

22.3K

Citations

H-Index

182

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Salford Royal Hospital Edinburgh Royal Infirmary

About

Robert J. Young is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, neurology, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	71	7.8K
2	Health Sciences	19	24	1.6K
3	Engineering	7	7	313
4	Natural Sciences	1	1	24
5	Nursing	1	1	10

Robert J. Young

166

Publications

20.2K

Citations

H-Index

Page 1

	Year	Citations
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 M R Stearne, S L Palmer, M S Hammersley,	1998	4.8K
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes D J Ewing, Christopher Martyn, Robert J. Young, Diabetes Care HypertensionHeart FailureHeart Rate TestsCardiovascular FunctionBlood Pressure	1985	1.4K
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 M R Stearne, S L Palmer, M S Hammersley, HypertensionPharmacotherapyBlood PressureMicrovascular DysfunctionAtherosclerosis	1998	1.4K
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid Alexandra Miller, Ronak Shah, Elena Pentsova, Nature Neuro-oncologyTumor InnervationCerebrospinal FluidBrain Tumor BiologyTumour Evolution	2019	609
Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Meng Law, Robert J. Young, James S. Babb, Radiology	2008	528
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma Sean M. McBride, Eric J. Sherman, C. Jillian Tsai, Journal of Clinical Oncology	2020	382
Efficacy of MEK inhibition in patients with histiocytic neoplasms Eli L. Diamond, Benjamin H. Durham, Gary A. Ulaner, Nature MedicineMalignant Blood DisorderHistopathologyPathologyMek Inhibition	2019	370
The Prevalence of Foot Ulceration and its Correlates in Type 2 Diabetic Patients: a Population‐based Study Sudhesh Kumar, H. Ashe, L.N. Parnell, Diabetic Medicine	1994	359
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison John McKnight, Sarah H. Wild, Maxine Lamb, Diabetic Medicine	2014	339
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 M R Stearne, S L Palmer, M S Hammersley, HypertensionCost Effectiveness RatiosCost Effectiveness AnalysisBlood PressureNon-pharmacological Intervention	1998	303

Page 1